LUNG Q4 2021 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena

LUNGPulmonx Corporation

$75M

Q4 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$14M+39.5% YoY

Gross Profit

$10M74.8% margin

Operating Income

-$12M-90.2% margin

Net Income

-$13M-94.9% margin

EPS (Diluted)

$-0.35

QoQ Revenue Growth

+3.4%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$12M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$235M

Total Liabilities

$42M

Stockholders' Equity

$193M

Cash & Equivalents

$148M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14M	$10M	+39.5%
Gross Profit	$10M	$7M	+44.8%
Operating Income	-$12M	-$9M	-32.2%
Net Income	-$13M	-$9M	-39.9%

Geographic Segments

UNITED STATES

$7M53%

EMEA

$5M40%

Asia Pacific

$872,0006%

Other International Geographical Areas

$79,0001%